Channel Therapeutics Corporation (CHRO)
NYSEAMERICAN: CHRO · Real-Time Price · USD
1.590
+0.110 (7.43%)
At close: Mar 28, 2025, 4:00 PM
1.710
+0.120 (7.55%)
After-hours: Mar 28, 2025, 7:36 PM EST
Channel Therapeutics Employees
As of December 31, 2023, Channel Therapeutics had 8 total employees, including 4 full-time and 4 part-time employees. The number of employees increased by 6 or 300.00% compared to the previous year.
Employees
8
Change (1Y)
6
Growth (1Y)
300.00%
Revenue / Employee
n/a
Profits / Employee
-$994,417
Market Cap
9.58M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 8 | 6 | 300.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | - | - |
CHRO News
- 3 months ago - Channel Therapeutics Highlights Differences Between NaV1.7 and NaV1.8 in Light of Recent Clinical Data on Suzetrigine - GlobeNewsWire
- 3 months ago - Channel Therapeutics Announces Positive Efficacy Data For a Depot Formulation of a NaV1.7 Inhibitor in a Preclinical In Vivo Nerve Block Model - GlobeNewsWire
- 4 months ago - Chromocell Announces Name Change to “Channel Therapeutics Corporation” and Provides Therapeutic Program Updates - GlobeNewsWire
- 5 months ago - Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain - GlobeNewsWire
- 5 months ago - Chromocell Announces Amendment to Stock Repurchase Plan - GlobeNewsWire
- 6 months ago - Chromocell to Participate in Life Sciences Investor Forum September 19th - GlobeNewsWire
- 8 months ago - Chromocell Announces Stock Repurchase Plan - GlobeNewsWire
- 9 months ago - Chromocell to Participate in the Virtual Investor Lunch Break Series - GlobeNewsWire